鉴定CDKN3作为调节神经母细胞细胞分化的关键基因
Alexandra Vernaza1, Daniela F Cardus1, Jadyn L Smith1
1Department of Chemistry and Biochemistry, Texas State University, San Marcos, Texas.
Journal of Cancer
|February 15, 2024
概括
循环素依赖性激酶抑制剂3 (CDKN3) 倒置诱导神经母细胞瘤细胞分化和神经细胞外生长. 高CDKN3水平与患者生存率差相关,这表明它在神经母细胞瘤进展中的作用.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 神经母细胞瘤是一种具有复杂细胞循环调节的儿科癌症.
- 确定神经母细胞瘤分化的调节者对于治疗策略至关重要.
研究的目的:
- 为了确定控制神经母细胞瘤分化的细胞循环调节剂.
- 研究循环素依赖性激酶抑制剂3 (CDKN3) 在神经母细胞瘤细胞分化和进展中的作用.
主要方法:
- 在BE(2) -C神经母细胞细胞中使用siRNA库进行高含量查 (HCS).
- 对细胞分化标志物的分析 (神经元外生长,NSE,βIII-tubulin,GAP43) 和增殖标志物的分析 (Ki67,PCNA).
- 与公共神经母细胞瘤患者数据集的相关性分析以及对CDKN3调节机制的调查 (N-Myc,miR-506-3p,视网膜酸).
主要成果:
- 显著诱导的神经母细胞瘤细胞分化和神经细胞外生长.
- 降低CDKN3降低了扩散标志物和殖民地形成.
- 高瘤CDKN3mRNA水平与患者生存率差的相关性.
- N-Myc通过转录促进了CDKN3的表达,而miR-506-3p和视网酸则对其进行了下调.
- 在一个差异化调节网络中,CDKN3与CDC6和CDK4相互作用.
结论:
- CDKN3在调节神经母细胞瘤细胞分化方面发挥着至关重要的作用.
- 通过N-Myc介导的CDKN3的转录调节是神经母细胞瘤的一个关键机制.
- 过度表达CDKN3可能会导致神经母细胞瘤的进展,因此需要进一步研究作为治疗点.
更多相关视频
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.7K
10:48Differentiation of a Human Neural Stem Cell Line on Three Dimensional Cultures, Analysis of MicroRNA and Putative Target Genes
Published on: April 12, 2015
10.0K
相关概念视频
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
